Luce, Michelle S.

HRN: 27-68-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 750MG (VIAL)
08/22/2025
08/29/2025
IV
750mg
Q8H
URINARY TRACT INFECTION
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines